"10.1371_journal.pone.0098153","plos one","2015-03-19T00:00:00Z","Niels Andreasen; Monica Simeoni; Henrik Ostlund; Pia I Lisjo; Tormod Fladby; Amy E Loercher; Gerard J Byrne; Frances Murray; Paul T Scott-Stevens; Anders Wallin; Yinghua Y Zhang; Lena H Bronge; Henrik Zetterberg; Agneta K Nordberg; Astrid J Yeo; Shahid A Khan; Jan Hilpert; Prafull C Mistry","Geriatriska Kliniken, Karolinska Universitetssjukhuset, Huddinge, Stockholm, Sweden; GlaxoSmithKline Quantitative Sciences, Stockley Park, United Kingdom; Memory Clinic, Skanes University Hospital, Malmo, Sweden; Clinical Operations, TrialCo AB, Gothenburg, Sweden; Division of Medicine and Laboratory Sciences, Clinical Neuroscience Group, Akershus University Hospital, Lørenskog, Norway; Clinical Immunology, GlaxoSmithKline, Upper Merion, Pennsylvania, United States of America; Discipline of Psychiatry, School of Medicine, University of Queensland, Mental Health Center, Royal Brisbane & Women’s Hospital, Herston, Australia; CPSSO Projects Clinical Platforms and Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America; Platform Technology and Science-Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Ware, United Kingdom; Memory Clinic, Sahlgrenska University Hospital, Mölndal, Sweden; Quantitative Sciences, GlaxoSmithKline, Upper Merion, Pennsylvania, United States of America; Aleris Diagnostic AB Sabbatsberg, Stockholm, Sweden; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; UCL Institute of Neurology, Queen Square, London, United Kingdom; Quantitative Sciences, GlaxoSmithKline, Stevenage, United Kingdom; Biopharm Project Management, GlaxoSmithKline, Stevenage, United Kingdom; Neurosciences Therapeutic Area, GlaxoSmithKline, Shanghai, China","Conceived and designed the experiments: MS TF AW. Performed the experiments: PCM JH AW. Analyzed the data: NA MS HO PIL TF AEL GJB FM PTS-S AW YYZ LHB HZ PCM AKN AJY JH. Contributed reagents/materials/analysis tools: AEL PTS-S PCM. Wrote the paper: NA MS HO PIL TF AEL GJB FM PTS-S AW YYZ LHB HZ PCM AKN AJY SAK JH.","MS, AL, FM, PSS, YZ, PM, AY, SK & JH are employees of GSK, whose company funded this study. PIL is an employee of TrialCo AB. LH is an employee of Aleris Diagnostic AB Sabbatsberg. The Independent Data Monitoring Committee included Trident Clinical Research Pty Ltd who provided study conduct and monitoring. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2015","03","Niels Andreasen","NA",18,TRUE,3,3,17,18,TRUE,TRUE,FALSE,0,NA,FALSE
